141 related articles for article (PubMed ID: 5383911)
1. [Vaso-active substances].
Cah Anesthesiol; 1969 Nov; 17(7):787-833. PubMed ID: 5383911
[No Abstract] [Full Text] [Related]
2. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
3. The dilemma of vasopressors and vasodilators in the therapy of shock.
Shoemaker WC; Brown RS
Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
[No Abstract] [Full Text] [Related]
4. [Haemodynamic study of septic shock. Apropos of 26 cases].
Motin J; Petit P; Bouletreau P; Latarjet J
Nouv Presse Med; 1974 Jun; 3(23):1481-5. PubMed ID: 4152543
[No Abstract] [Full Text] [Related]
5. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
Lee CS
Crit Care Nurse; 2006 Dec; 26(6):17-23. PubMed ID: 17123948
[No Abstract] [Full Text] [Related]
6. Responses of the coronary arterial system of the horse to catecholamines.
Webster JE; Bowie WC
Am J Vet Res; 1971 Nov; 32(11):1677-85. PubMed ID: 5122147
[No Abstract] [Full Text] [Related]
7. [The significance of biologically active substances in regulating local vascular tonus].
Iordanov Iu
Eksp Med Morfol; 1991; 30(1):45-50. PubMed ID: 1884688
[No Abstract] [Full Text] [Related]
8. [Treatment of adult toxic shock].
Wang BE
Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):783-5. PubMed ID: 6675943
[No Abstract] [Full Text] [Related]
9. [Current status of the treatment of infectious shock].
Rapin M
Anesth Analg (Paris); 1969; 26(5):753-62. PubMed ID: 5368578
[No Abstract] [Full Text] [Related]
10. [Experiences in the treatment of septic shock in childbirth].
Schwarz R; Retzke U; Brückner H
Anaesthesist; 1971 Apr; 20(4):127-35. PubMed ID: 5553650
[No Abstract] [Full Text] [Related]
11. [Round-table discussion on cardiovascular collapses].
Cah Coll Med Hop Paris; 1969 Sep; 10(11):907-20. PubMed ID: 5376762
[No Abstract] [Full Text] [Related]
12. [Biochemical aspects of vascular pharmacology (literature review)].
Nikulin AA; Smirnov PA
Farmakol Toksikol; 1971; 34(4):504-9. PubMed ID: 4400799
[No Abstract] [Full Text] [Related]
13. [Shock: changes in perspectives. Differential therapeutic problems in intensive care of shock].
Schuster HP
Internist (Berl); 1982 Aug; 23(8):463-9. PubMed ID: 6752087
[No Abstract] [Full Text] [Related]
14. [Emergency therapy in manifested shock].
Bartels O
Fortschr Med; 1973 Jun; 91(18):777-80. PubMed ID: 4723861
[No Abstract] [Full Text] [Related]
15. [Septic shock (author's transl)].
Schmidt D
Zentralbl Chir; 1976; 101(18):1089-102. PubMed ID: 824889
[No Abstract] [Full Text] [Related]
16. [On the use of vasoactive drugs].
Cortinovis A; Cortinovis R; Pellegrino L
Chir Patol Sper; 1968; ():Suppl 5:156+. PubMed ID: 5743361
[No Abstract] [Full Text] [Related]
17. Septic shock: the initial moments and beyond.
Lam SW; Bauer SR; Guzman JA
Cleve Clin J Med; 2013 Mar; 80(3):175-84. PubMed ID: 23456468
[TBL] [Abstract][Full Text] [Related]
18. [Shock and its treatment wuth chemotherapeutic agents].
Fujita M; Iwabuchi K
Jibiinkoka; 1969 Oct; 40(10):843-50. PubMed ID: 5812656
[No Abstract] [Full Text] [Related]
19. [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies].
Grabarić B; Pantelić D
Vojnosanit Pregl; 1973; 30(5):452-4. PubMed ID: 4772855
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of new therapeutic concepts in septic shock.
Martinez JT; Fernandez G; Vazquez-Leon H
Obstet Gynecol; 1966 Feb; 27(2):296-301. PubMed ID: 5325605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
